Eyolfson D A, Dhalla N S
Division of Cardiovascular Sciences, St. Boniface General Hospital Research Centre, Winnipeg, Manitoba, Canada.
Basic Res Cardiol. 1989 Jul-Aug;84(4):414-20. doi: 10.1007/BF02650876.
The effects of some Class I antiarrhythmics (quinidine, procainamide and lidocaine) and some Class II antiarrhythmics (propranolol, atenolol and acebutolol) on canine cardiac sarcolemmal Na+-Ca2+ exchange activity were studied. Both quinidine (5-100 microM) and procainamide (1-100 microM), unlike lidocaine, inhibited Na+-dependent Ca2+ uptake in sarcolemmal vesicles. The effective concentrations of these agents were well within their respective therapeutic ranges; about 30% inhibition was seen by 10 microM quinidine or procainamide. Propranolol showed a 25% inhibition of the Na+-Ca2+ exchange activity at 100 microM, which concentration is well above its therapeutic range. Acebutolol (0.1-100 microM) had no significant effects, whereas atenolol (10-100 microM), which appeared to inhibit Na+-dependent Ca2+ uptake, also stimulated nonspecific Ca2+ uptake. These results indicate that the cardiac sarcolemmal Na+-Ca2+ exchange system may be one of the sites for the antiarrhythmic actions of quinidine and procainamide.
研究了一些Ⅰ类抗心律失常药(奎尼丁、普鲁卡因胺和利多卡因)以及一些Ⅱ类抗心律失常药(普萘洛尔、阿替洛尔和美托洛尔)对犬心肌肌膜钠钙交换活性的影响。与利多卡因不同,奎尼丁(5 - 100微摩尔)和普鲁卡因胺(1 - 100微摩尔)均抑制肌膜囊泡中钠依赖性钙摄取。这些药物的有效浓度均在各自的治疗范围内;10微摩尔的奎尼丁或普鲁卡因胺可产生约30%的抑制作用。普萘洛尔在100微摩尔时对钠钙交换活性有25%的抑制作用,该浓度远高于其治疗范围。美托洛尔(0.1 - 100微摩尔)无显著影响,而阿替洛尔(10 - 100微摩尔)似乎抑制钠依赖性钙摄取,但同时也刺激非特异性钙摄取。这些结果表明,心肌肌膜钠钙交换系统可能是奎尼丁和普鲁卡因胺抗心律失常作用的位点之一。